Singapore, Sept. 24 -- GCCL (Global Clinical Central Lab), aSouth Korea-based leading provider of clinical trial sample analysis, and Frontage Laboratories, Inc., aUSbased full-service contract research organisation (CRO), have signed a strategic Memorandum of Understanding (MoU) pursuant to which they intend to explore ways to strengthen their presence in the global clinical trial market.

In signing the MOU, GCCL and Frontage intend to consider opportunities to leverage the complementary services and networks of both companies to enhance competitiveness, particularly inthe United StatesandAsia-Pacific(APAC) regions, while driving mutual growth. In particular, during the signing ceremony, the two companies reaffirmed their commitment to ...